Andrew Serafin

CIK: 0001821460

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)3 (30.0%)

Derivative conversions

Awards (A)4 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (30.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

HRMY

Harmony Biosciences Holdings, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

HRMY
Harmony Biosciences Holdings, Inc.
Jan 25, 2026
Exercise(M)
Direct
2.6K shares-
HRMY
Harmony Biosciences Holdings, Inc.
Jan 25, 2026
Tax Payment(F)
Direct
1.1K shares at avg. $36.82$41K
HRMY
Harmony Biosciences Holdings, Inc.
Jan 24, 2026
Exercise(M)
Direct
2.5K shares-
HRMY
Harmony Biosciences Holdings, Inc.
Jan 24, 2026
Tax Payment(F)
Direct
1.1K shares at avg. $36.82$41K
HRMY
Harmony Biosciences Holdings, Inc.
Jan 22, 2026
Award(A)
Restricted Stock Units
Direct
12.2K shares-
HRMY
Harmony Biosciences Holdings, Inc.
Jan 22, 2026
Award(A)
Stock Option
Direct
42.6K shares-
HRMY
Harmony Biosciences Holdings, Inc.
Jan 25, 2025
Award(A)
Stock Option
Direct
36.5K shares-
HRMY
Harmony Biosciences Holdings, Inc.
Jan 25, 2025
Award(A)
Restricted Stock Units
Direct
10.4K shares-
HRMY
Harmony Biosciences Holdings, Inc.
Jan 24, 2025
Exercise(M)
Direct
2.5K shares-
HRMY
Harmony Biosciences Holdings, Inc.
Jan 24, 2025
Tax Payment(F)
Direct
865 shares at avg. $38.01$33K

		Type	Shares	Price		Ownership
Jan 25, 2026	HRMY Harmony Biosciences Holdings, Inc.	Exercise(M)	2,600	-	$0	Direct
Jan 25, 2026	HRMY Harmony Biosciences Holdings, Inc.	Tax Payment(F)	1,126	$36.82	$41,459	Direct
Jan 24, 2026	HRMY Harmony Biosciences Holdings, Inc.	Exercise(M)	2,500	-	$0	Direct
Jan 24, 2026	HRMY Harmony Biosciences Holdings, Inc.	Tax Payment(F)	1,116	$36.82	$41,091	Direct
Jan 22, 2026	HRMY Harmony Biosciences Holdings, Inc.	Award(A) Restricted Stock Units	12,200	-	-	Direct
Jan 22, 2026	HRMY Harmony Biosciences Holdings, Inc.	Award(A) Stock Option	42,600	-	-	Direct
Jan 25, 2025	HRMY Harmony Biosciences Holdings, Inc.	Award(A) Stock Option	36,500	-	-	Direct
Jan 25, 2025	HRMY Harmony Biosciences Holdings, Inc.	Award(A) Restricted Stock Units	10,400	-	-	Direct
Jan 24, 2025	HRMY Harmony Biosciences Holdings, Inc.	Exercise(M)	2,500	-	$0	Direct
Jan 24, 2025	HRMY Harmony Biosciences Holdings, Inc.	Tax Payment(F)	865	$38.01	$32,879	Direct

1-10 of 10 transactions

About Serafin Andrew

Serafin Andrew (SEC CIK 0001821460) files insider reports with the SEC as CHIEF STRATEGY OFFICER of Harmony Biosciences Holdings, Inc. (HRMY).

Signal8 holds 2 ownership filings by Serafin Andrew, all Form 4s, filed between Jan 28, 2025 and Jan 26, 2026. Those filings report 10 transactions, from Jan 24, 2025 to Jan 25, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Serafin Andrew's filings is in PLYMOUTH MEETING, PA.

Recent filings by Serafin Andrew

Jan 25, 2026: Option exercise of HRMY shares (Form 4, code M).
Jan 25, 2026: Tax withholding of HRMY shares (Form 4, code F).
Jan 24, 2026: Option exercise of HRMY shares (Form 4, code M).
Jan 24, 2026: Tax withholding of HRMY shares (Form 4, code F).
Jan 22, 2026: Grants or awards of HRMY derivative securities (2 lines, Form 4, code A).

Other insiders filing for Harmony Biosciences Holdings, Inc. (HRMY)

Budur Kumar, CHIEF MEDICAL OFFICER
Mollichella Stephen M., INT PRINCIAL FINANCIAL OFFICER
Germano Geno J, Director
Szyper Linda M, Director
Philip Ron M, Director
Graf R. Mark, Director

How to read Form 4 transaction codes